Clinical and endoscopic evaluation of gastroesophageal reflux disease in patients successfully treated with esomeprazole

Select Content Type
Resources
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
Endoscopy_thumbnail
Detail Image
Endoscopy_mobile
Book Detail
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

Esomeprazole was assessed for its effectiveness and safety in treating patients with erosive esophagitis confirmed by endoscopy. All participants took the medication once daily, and those not fully healed after four weeks continued for another four. Most patients experienced healing and significant relief from symptoms like heartburn within a short period. The medication was generally well tolerated, with only mild side effects such as headache and stomach discomfort. Overall, esomeprazole proved to be both effective and safe for managing erosive esophagitis.

Published Date